卵母细胞玻璃化冷冻用于医学与非医学原因的生育力保存
本文综述卵母细胞玻璃化冷冻技术在生育力保存中的应用。获益人群包括因医源性或自然卵巢功能衰竭风险的女性及因各种原因推迟生育的健康女性。取卵年龄强烈影响生殖预后,建议选择性生育力保存者在35岁前决定;癌症和子宫内膜异位症患者结局更差,获卵数在所有人群中与成功密切相关。
要点
- 卵母细胞玻璃化冷冻的存活率和临床结局(含累积活产率)令人满意。
- 取卵年龄强烈影响生育力保存后的生殖预后,建议35岁前决定。
- 获卵数与成功率密切相关,增加少量卵母细胞即可显著改善结局。
核心结论
- 卵母细胞玻璃化冷冻技术日趋成熟,已广泛应用于医学和非医学原因的生育力保存。
- 取卵时年龄是影响生育力保存后生殖预后的最强因素之一。
- 获卵数与所有人群的成功率密切相关,增加少量卵母细胞即可显著改善结局。
研究设计与样本
- 本文为综述,总结卵母细胞玻璃化冷冻用于生育力保存的证据。
主要发现
- 卵母细胞玻璃化冷冻后存活率和临床结局(包括累积活产率)令人满意。
- 取卵年龄强烈影响生育力保存后的生殖预后。
- 癌症患者生育力保存后的生殖结局更差,但疾病与生殖结局的直接关联尚未证实。
- ≤35岁子宫内膜异位症患者取卵前行囊肿剥除术者结局差于年龄匹配的未手术者。
- 获卵数在所有人群中与成功密切相关,增加少量卵母细胞即可显著改善结局,尤其健康年轻患者。
关键数值与推荐
- 建议选择性生育力保存患者在35岁前决定,以显著提高成功机会。
临床怎么用
- 对因医学或非医学原因需生育力保存的女性,可提供卵母细胞玻璃化冷冻选项。
- 咨询时应告知取卵年龄对成功率的影响,鼓励适宜人群在35岁前决策。
- 癌症和子宫内膜异位症(尤其取卵前曾行囊肿剥除术)患者应被告知生殖预后可能更差。
- 制定取卵策略时需考虑获卵数对成功率的密切影响。
局限性
- 癌症与生殖结局的直接关联尚未证实。
- 年龄影响在癌症和子宫内膜异位症患者中亦被观察到,但相关证据仍需进一步积累。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Growing evidence of successful outcomes achieved with the oocyte vitrification technique has greatly contributed to its application in the field of fertility preservation (FP). The population that can benefit from FP includes women at a risk of losing their ovarian function because of either iatrogenic causes or natural depletion of their ovarian reserve. Therefore, oncological patients and healthy women who wish to delay motherhood for various reasons-elective FP-are currently being offered this option. Satisfactory oocyte survival rates and clinical outcomes, including cumulative live birth rates, have been reported in recent years. These studies show that age at oocyte retrieval strongly affects reproductive prognosis after FP. Therefore, elective FP patients should be encouraged to decide before they reach the age of 35 years to significantly increase their chances of success. The effect of age has also been observed in patients with cancer and women diagnosed with endometriosis. The reproductive outcome after FP is worse in patients with cancer, but a direct association between the disease and reproductive outcome is yet to be proven. Young patients (≤35 years) with endometriosis who have undergone cystectomy before oocyte retrieval for FP have worse outcomes than nonoperated women in age-matched groups. In addition, the number of oocytes used per patient is closely related to success in all populations, with considerable improvement in the result with the addition of a few oocytes, especially in healthy young patients.
引用
- Cobo A, García-Velasco JA, Remohí J, et al. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. Fertil Steril. 2021. PMID: 33933172. doi:10.1016/j.fertnstert.2021.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。